Hyderabad, Feb 25 (Agency) Day 2 on Friday, Asia’s largest life-sciences and healthcare forum BioAsia 2022 held in virtual mode here on Friday boasted extensive discussions among the world’s finest healthcare stakeholders. One of the chief highlights of the 19th edition of BioAsia 2022, was the keynote speech by Alex Gorsky, Executive Chairman, Johnson & Johnson. Gorsky emphasized greatly on how the world is on the cusp of making a technological shift and the need for change in the trajectory of human health. The address also touched on the agility and accessibility of essential innovation. He said that all eyes are on Asia today, while the world is noticing how India as a superhub for pharmaceutical divisions is touching the lives of millions and has contributed significantly to the current fight against Covid-19.
Acknowledging the urgent relevance of BioAsia 2022’s theme of being “Future-ready”, Gorsky said “I couldn’t agree more with the theme of the conference, it is forward leaning. There are tremendous developments for the rest of the world that are coming out of Asia now. We will be influenced by the innovators in Asia with their talent, ingenuity, and the agility”. A home for over 4 billion people, Asia was noted to be the most exciting hub for innovation and potential. Gorsky said he believes that the region will be at the global forefront over the next decade. “We believe that healthcare spending is expected to increase up to USD 5 trillion in the region by 2030. With intense concentration on areas like technical expertise, ground-breaking innovation, and just really incredible market opportunities, some of the most exciting innovations and ideas in healthcare right now are coming from Asia, which has 36 per cent of the unicorns today,” he added.